The European Sting is Your democratic, independent and top quality political newspaper specialized in European Union News. Unique Features: iSting & Harry Sting
This article is brought to you in association with the European Commission. Today, the Council has adopted its position on the November 2020 Commission proposal to give the European Medicines Agency (EMA) a stronger role in crisis preparedness and management. This proposal would allow the EMA to facilitate activities such as monitoring and mitigating the risk […]
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Craig Kennedy, Senior Vice President, Global Supply Chain Management, Merck Sharp & Dohme From COVID-19 to cholera, health crises expose unequal access to care. With the right regulations and technology in place, drones could be used to deliver […]
This article was exclusively written for The European Sting by Ms. Sahiba Maniar, a 6th Semester Medical student from India, who is extremely passionate about human rights. She is affiliated to the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do not necessarily […]
This article was exclusively written for the The European Sting by Ms. Aurimarcia Torres, a second year medical student at the Federal University of Rio Grande do Norte in Natal, Brazil. She is affiliated to the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do […]
This article is brought to you in association with the European Parliament. The new law adopted on Wednesday aims to avoid duplicating national assessments to determine a medicine’s added value that help EU countries decide on pricing. MEPs highlight that there are many barriers to accessing medicine and innovative technologies in the EU, the main ones […]
This article is brought to you in association with the European Parliament. The new law aims to avoid duplicating national assessments to determine a medicine’s added value that help EU countries decide on pricing and reimbursement. MEPs highlight that there are many barriers to accessing medicine and innovative technologies in the EU, the main ones being […]
The European Sting - Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology - europeansting.com 